Clinical Trials Directory

Trials / Completed

CompletedNCT02086110

Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism

A Pilot Study Examining Microbiota Composition in Children With Autism and Gastrointestinal Symptoms After Use of Bifidobacterium Infantis and Milk Oligosaccharides

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
2 Years – 11 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the tolerability of dietary supplements and if these supplements can promote a healthy bacterial environment in the intestines of children with autism spectrum disorders and gastrointestinal complaints.

Detailed description

This study investigates the feasibility, tolerability, and effects of a dietary supplement on the intestinal flora of children with autism spectrum disorders. This study is divided into two parts, each five weeks long, with a two week break in between. During one part of the study, a prebiotic (milk oligosaccharides from bovine colostrum) will be given. During the other part of the study, the synbiotic composed of the prebiotic and probiotic (bifidobacterium infantis) will be given. Stool will be analyzed at the end of each study arm to determine content of bifidobacteria. On May 8, 2018, we updated the study start and completion dates to the actual (instead of anticipated) dates. On May 30-31, 2019, we updated the study results section.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSynbiotic
DIETARY_SUPPLEMENTPrebiotic

Timeline

Start date
2014-06-06
Primary completion
2015-11-16
Completion
2015-11-16
First posted
2014-03-13
Last updated
2019-08-01
Results posted
2019-08-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02086110. Inclusion in this directory is not an endorsement.